|
|
Volumn 13, Issue 4, 2009, Pages 311-
|
|
Targeting the ubiquitin proteasome pathway for the treatment of septic shock in patients.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PROTEASOME;
PROTEINASE INHIBITOR;
UBIQUITIN;
ANIMAL;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
MOUSE;
MULTIPLE MYELOMA;
PATHOPHYSIOLOGY;
SEPTIC SHOCK;
SIGNAL TRANSDUCTION;
TRANSGENIC MOUSE;
ANIMALS;
MICE;
MICE, TRANSGENIC;
MULTIPLE MYELOMA;
NF-KAPPA B;
PROTEASE INHIBITORS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
SHOCK, SEPTIC;
SIGNAL TRANSDUCTION;
UBIQUITIN;
MLCS;
MLOWN;
|
|
EID: 75549089338
PISSN: None
EISSN: 1466609X
Source Type: Journal
DOI: 10.1186/cc7946 Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
